Skip to Main Content

Business

STAT ‘s award-winning team of reporters covers every major health care industry in the United States, including pharma, biotech, hospitals, insurance, health tech and medical devices.

Latest

The Readout Elaine Chen

Scholar Rock sees SMA data boosting obesity effort

Health tech Mario Aguilar

STAT Plus: Biogen turns to telehealth company to boost its postpartum depression drug

The Readout Meghana Keshavan

The biotech news stories you need to read this morning

Politics Rachel Cohrs Zhang

STAT Plus: Trump backs off proposal to slash prescription drug prices by linking them to foreign countries

The Readout STAT Staff

STAT Plus: WuXi looks to sell assets as BIOSECURE Act looms

Insurance Tara Bannow and Bob Herman

STAT Plus: Medicare Advantage market expected to grow in 2025, despite big changes from insurers

Politics John Wilkerson

STAT Plus: Higher insurance costs eat into savings from drug pricing law by more than expected

Business Bob Herman

STAT Plus: UnitedHealth sues Medicare to reverse downgraded star ratings

All Coverage

The Readout Elaine Chen

STAT Plus: Dockworker strike puts drug supplies at risk

Health tech Brittany Trang

STAT Plus: Epic and Particle dragged a nonprofit into their antitrust fight. Here’s what you need to know

advertisement

Health tech Mario Aguilar

STAT Plus: ResMed CEO on how wearables, GLP-1s will impact sleep apnea device sales

Breaking News Bob Herman

STAT Plus: Humana tumbles as insurer faces $3 billion hit to revenue over lower Medicare star ratings

The Readout Elaine Chen

STAT Plus: Lilly invests $4.5 billion in a new research hub

D.C. Diagnosis Sarah Owermohle

STAT Plus: The health care issues we’re watching in tonight’s VP debate

Business Tim Logan — The Boston Globe

STAT Plus: CVS to cut 2,900 jobs and is reportedly mulling a breakup

The Readout Elaine Chen

STAT Plus: The latest obesity drug updates happening right now

Health Care Inc. Newsletter Bob Herman

STAT Plus: How much more are health care’s bosses making than their employees?

Health tech Katie Palmer

STAT Plus: Q&A: Why medical AI and value-based care may be made for each other

Business Mark Arsenault — Boston Globe and Jessica Bartlett — Boston Globe

STAT Plus: Steward Health Care CEO Ralph de la Torre will resign

The Readout Meghana Keshavan

STAT Plus: Why are Genentech cancer researchers worried?

Politics Bob Herman

STAT Plus: Biden administration axes proposal to mandate more drug price transparency in Medicaid

Hospitals Tara Bannow

STAT Plus: Two reports, two dramatically different views of nonprofit hospitals’ tax breaks

The Readout Elaine Chen

STAT Plus: Biotech’s real estate market is still upside down

The Readout Elaine Chen

STAT Plus: The science behind Summit’s success, 23andMe’s fate, and more biotech news updates

The Readout Elaine Chen

STAT Plus: Metsera’s GLP-1 drug has potential for monthly dosing, new data show

Biotech Brittany Trang

STAT Plus: Novartis strikes AI drug development deal with Generate:Biomedicines

Politics Leslie Walker and Dan Gorenstein

STAT Plus: The U.S. has relied on cheap, effective generic drugs for 40 years. Now that promise is under threat

Health Care Inc. Bob Herman

STAT Plus: Will prescription drugs get prior authorization reform?

Health tech Casey Ross

STAT Plus: Electronic health records giant Epic Systems sued over alleged monopolistic practices